In vivo evidence demonstrated that genetic ablation of RAGE reduced the infarct volume and abrogated macrophage activation in mice [17] and that the knockdown of HMGB1 expression by intra-striatal infection of HMGB1-shRNA reduced infarct size and microglia activation in experimental stroke models [18]. This evidence concerns the gene AGER and stroke disorder.